Login to Your Account



Rituxan, Avastin Lead Q1 Sales As Genentech Beats Consensus

By Karen Pihl-Carey


Wednesday, April 13, 2005
Fueled by four new product launches over the last two years, Genentech Inc. recorded a healthy first quarter in terms of both dollars and data. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription